BPC-157 - Red Flags, Regulators, and the Cancer Question episode artwork

EPISODE · Apr 11, 2026 · 24 MIN

BPC-157 - Red Flags, Regulators, and the Cancer Question

from BPC-157 · host Inception Point Ai

Host Ben Synth examines BPC-157, a biohacking peptide with zero human clinical trials and an FDA Category 2 safety warning. We explore regulatory red flags, theoretical cancer risks from angiogenesis, purity concerns in unregulated markets, and why promising rodent studies don't guarantee human safety.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Host Ben Synth examines BPC-157, a biohacking peptide with zero human clinical trials and an FDA Category 2 safety warning. We explore regulatory red flags, theoretical cancer risks from angiogenesis, purity concerns in unregulated markets, and why promising rodent studies don't guarantee human safety.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

NOW PLAYING

BPC-157 - Red Flags, Regulators, and the Cancer Question

0:00 24:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Short Poetry Collection 157 by Various Loyal Books This is a collection of 23 poems read by volunteers for June 2016. Today's discussion on unraveling BPC 157 Peptide Infinity Peptides We will discuss the preclinical trial information on Bpc157 what have we heard what have we experienced, along with where does it come from.‘RSSVERIFY’ Hypnosis With Joseph Clough Joseph Clough Joseph Clough, a British Celebrity Hypnotist and Bestselling Hay House Author. He lives in San Diego, California. He struggled with "Imposter Syndrome", worry and doubts for 18 years and overcame it with what you are about to experience. With over 19,000,000+ downloads/views and listened to in 157 countries around the world, now is your time to achieve success...because you deserve it.Disclaimer:By using Joseph Clough's free or paid work you expressly agree that your use of this App is at your sole risk.The information, techniques and exercises provided within these free and paid products are for educational purposes only. Do not use the techniques or exercises contained within some of these products whilst driving or operating machinery, or if you suffer from epilepsy, clinical depression or any other nervous or psychiatric conditions. The information provided is not a substitute for proper medical advice. If in doubt, please consult your doctor or licensed medical practiti 15 Minutes Customer Obsession Peggy Amelung You have read the books. Attended the conferences. Mapped the customer journey. Trained the team. And something still feels like it is not quite working. This podcast is the honest explanation for why. 15 Minutes Customer Obsession is hosted by Peggy Amelung — Integral Coach, founder of the GHX™ (Genuine Human Xperience) Framework, and alumna of Ritz-Carlton and Bvlgari Hotels. Each episode takes one question most CX and leadership content refuses to ask: not what great organisations do differently, but who their leaders have become. After 157 German-language episodes and 20 years inside the world's most demanding service environments, Peggy has arrived at one conclusion that changes everything: The quality of human experience you can create for another person is a direct function of what you have developed within yourself. You cannot give what you have not grown. This is not a metaphor. It is the mechanism behind every CX programme that fails, every culture initiative that d

Frequently Asked Questions

How long is this episode of BPC-157?

This episode is 24 minutes long.

When was this BPC-157 episode published?

This episode was published on April 11, 2026.

What is this episode about?

Host Ben Synth examines BPC-157, a biohacking peptide with zero human clinical trials and an FDA Category 2 safety warning. We explore regulatory red flags, theoretical cancer risks from angiogenesis, purity concerns in unregulated markets, and why...

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this BPC-157 episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!